Company profile: Prosarix
1.1 - Company Overview
Company description
- Provider of computational approaches and products to assist drug discovery for biotech and pharmaceutical sectors, including ProtoDiscovery, a validated, state-of-the-art computational platform.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Prosarix
Colwiz
HQ: United Kingdom
Website
- Description: Provider of a free research management, collaboration and productivity platform for individual researchers, groups, departments and organizations, featuring graphing tools. Delivered via web, desktop (Windows, Mac, Linux) and mobile applications synced in real time, it manages the entire research lifecycle from an initial idea.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Colwiz company profile →
Sciwheel
HQ: United Kingdom
Website
- Description: Provider of customizable, intuitive, and accessible tools to advance research and discovery, enabling research and data to be published fast, openly, and cost-effectively to accelerate use, reuse, and potential impact.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sciwheel company profile →
Transition Bio
HQ: United States
Website
- Description: Provider of condensate technology for drug discovery and diagnostics, offering PhaseScanTM, a microfluidics-based high-throughput molecular screen to identify drug candidates and mechanisms of action; CelPhaseTM, high-content cellular imaging to visualize condensates in disease models and patient samples for target validation; and DeePhaseTM, an AI engine using proprietary datasets for target discovery and hit identification.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Transition Bio company profile →
Clinical Ink
HQ: United States
Website
- Description: Provider of eSource solutions for the clinical trials industry, offering software to record validated source data, comments, and explanations on protocol-specific electronic documents via mobile devices, including its SureSource electronic source solution that captures data required by trial protocols.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Clinical Ink company profile →
Circuit Clinical
HQ: United States
Website
- Description: Provider of turnkey, end-to-end clinical trial solutions as an integrated research organization. Services include community research networks with traditional, hybrid, and decentralized visits; MD Prescreen led by research nurses and medical professionals; biospecimen collection; Phase I–IV trial management focused on diverse, community populations; and an IRO with direct EMR access to 2.5M+ participants.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Circuit Clinical company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Prosarix
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Prosarix
2.2 - Growth funds investing in similar companies to Prosarix
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Prosarix
4.2 - Public trading comparable groups for Prosarix
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →